Roles and crosstalks of macrophages in diabetic nephropathy

HD Li, YK You, BY Shao, WF Wu, YF Wang… - Frontiers in …, 2022 - frontiersin.org
Diabetic nephropathy (DN) is the most common chronic kidney disease. Accumulation of
glucose and metabolites activates resident macrophages in kidneys. Resident macrophages …

RNA N6‐methyladenosine modifications and potential targeted therapeutic strategies in kidney disease

WJ Ni, H Lu, NN Ma, BB Hou, J Zeng… - British Journal of …, 2023 - Wiley Online Library
Epigenetic modifications have received increasing attention and have been shown to be
extensively involved in kidney development and disease progression. Among them, the …

Research progress of Pyroptosis in Diabetic Kidney disease

Q Fan, R Li, H Wei, W Xue, X Li, Z Xia, L Zhao… - International Journal of …, 2024 - mdpi.com
Pyroptosis, known as one typical mode of programmed cell death, is generally characterized
by the cleaved gasdermin family (GSDMs) forming pores in the cell membrane and inducing …

[HTML][HTML] WTAP/YTHDF1-mediated m6A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs

Q Chen, L Ao, Q Zhao, L Tang, Y Xiong, Y Yuan… - Journal of Advanced …, 2024 - Elsevier
Introduction The immunosuppressive capacity of mesenchymal stem cells (MSCs) is
dependent on the “license” of several pro-inflammatory factors to express …

The potential role of vitamin D binding protein in kidney disease: a comprehensive review

JR Delanghe, C Delrue, R Speeckaert… - Acta Clinica …, 2024 - Taylor & Francis
Chronic kidney disease (CKD) is a growing health concern with a complex etiological
landscape. Among the numerous factors implicated, vitamin D binding protein (VDBP) has …

[HTML][HTML] N6-methyladenosine RNA methylation in diabetic kidney disease

J Huang, F Yang, Y Liu, Y Wang - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, and
hyperglycemic memory associated with diabetes carries the risk of disease occurrence …

N6-methyladenine RNA methylation epigenetic modification and diabetic microvascular complications

Y Wang, J Zou, H Zhou - Frontiers in Endocrinology, 2024 - frontiersin.org
N6-methyladensine (m6A) has been identified as the best-characterized and the most
abundant mRNA modification in eukaryotes. It can be dynamically regulated, removed, and …

Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis

H Chen, L Ni, X Wu - Renal Failure, 2023 - Taylor & Francis
Objective To systematically evaluate the correlation between urinary vitamin D-binding
protein (VDBP) and diabetic kidney disease and to evaluate the relationship between …

RNA methylation pattern and immune microenvironment characteristics mediated by m6A regulator in ischemic stroke

K Jia, W Xia, Q Su, S Yang, Y Zhang, X Ni, Z Su… - Frontiers in …, 2023 - frontiersin.org
Background: Ischemic stroke (IS) is a highly heterogeneous disease. Recent studies have
shown that epigenetic variables affect the immune response. However, only a few studies …

[HTML][HTML] A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and …

R Tan, J Jia, T Li, L Wang, F Kantawong - Biomedicine & Pharmacotherapy, 2024 - Elsevier
The intricate crosstalk between long noncoding RNAs (lncRNAs) and epigenetic
modifications such as chromatin/histone methylation and acetylation offer new perspectives …